On the stock market since 2021, it operates in the world of health and science. It has 8,542 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 21% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $54.5M would still be left in the vault — a solid cushion for hard times.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
Clearly above the class average — a step short of the very top.
Sales are growing strongly for its sector.
The stock has been running stronger than the market lately.
No real weak spot in any of the five subjects — a balanced report card.
The stock trades 23% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 18% a year on average.
There is $248.6M in the vault; even if every debt were paid off, $54.5M would remain.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
The company’s market value is 498 times its annual profit. Even a small disappointment could hit the price hard.
Costs swallow the gains that sales growth brings in.
On our five-subject report card, LFST sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: LFST is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.